针对流行性流感候选疫苗的生产和免疫反应,作为对流传的H5N1流感病毒的准备
Paulo Lee Ho1, Yordanka Medina-Armenteros1, Lívia Mendonça Munhoz Dati1
1BioIndustrial Center, Butantan Institute and Butantan Foundation, São Paulo 05503-900, SP, Brazil.
Vaccines
|June 27, 2025
概括
开发有效的H5N1流感疫苗对于疫情准备至关重要. 这项研究表明,需要一种特定的候选疫苗病毒 (IDCDC RG-71A) 结合辅助剂和两剂剂量计划,才能对流通的H5N1菌株产生强烈的免疫反应.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 全球H5N1流感病毒的传播构成了严重的公共卫生威胁.
- 疫情防控需要开发针对相关H5N1菌株的有效疫苗.
研究的目的:
- 来自不同类型的基于蛋的H5N1单价抗原的生产和表征.
- 在大鼠模型中评估这些抗原的免疫性,有或没有辅助剂.
主要方法:
- 无活化H5N1疫苗的工业规模生产和表征 (分类2.3.4.4b,2.3.2.1c,2.3.4).
- 有或没有IB160辅助剂的疫苗配方.
- 在一次或两次剂量后对大鼠的免疫反应 (IgG,HI,微中和) 的评估.
主要成果:
- 成功地在工业规模生产了三种单价H5N1疫苗抗原.
- 在单价疫苗中观察到类特异性抗体反应.
- 将疫苗与IB160辅助剂结合起来,可以增强所需的免疫反应.
结论:
- 该IDCDC RG-71A候选疫苗病毒适用于占主导地位的H5N1类别2.3.4.4b.
- 辅助剂和两剂免疫接种方案是诱导强效免疫反应所必需的.
更多相关视频
12:18Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System
Published on: November 6, 2013
24.3K
07:15Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity
Published on: November 22, 2021
2.5K
相关概念视频
Vaccinations
45.3K
Overview
45.3K
Immune Response Against Viral Pathogens
934
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
934
